Charles Gayer
Vermögen: 4 Mio $ am 30.06.2026
Vermögen: 4 Mio $ am 30.06.2026
Charles K.
Gayer is President, Chief Executive Officer & Director at BioCryst Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Gayer was Head-US & Global Commercial Business at Grifols Therapeutics, Inc. Education includes an undergraduate degree from Princeton University and an MBA from The Fuqua School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.04.2026 | 364’620 ( 0.14% ) | 4 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.01.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutic products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutic products | Health Technology |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen